Vimedimex Medi – Pharma JSC (STC:VMD) Net Margin %: 0.00% (As of . 20)


What is Vimedimex Medi – Pharma JSC Net Margin %?

Vimedimex Medi – Pharma JSC STC:VMD Net Margin % is 0.00% as of . 20.

Net margin is calculated as Net Income divided by its Revenue. Vimedimex Medi – Pharma JSC's Net Income for the three months ended in . 20 was ₫0.00 Mil. Vimedimex Medi – Pharma JSC's Revenue for the three months ended in . 20 was ₫0.00 Mil. Therefore, Vimedimex Medi – Pharma JSC's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Vimedimex Medi – Pharma JSC's Net Margin % or its related term are showing as below:


STC:VMD's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Vimedimex Medi – Pharma JSC  (STC:VMD) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Vimedimex Medi – Pharma JSC Net Margin % Related Terms

Vimedimex Medi – Pharma JSC Net Margin % Historical Data

* Premium members only.

The historical data trend for Vimedimex Medi – Pharma JSC's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimedimex Medi – Pharma JSC Net Margin % Chart

Vimedimex Medi – Pharma JSC Annual Data
Trend
Net Margin %

Vimedimex Medi – Pharma JSC Quarterly Data
Net Margin %

STC:VMD vs GOVX, MBVXQ, HSTC: Net Margin % Comparison

For the Biotechnology subindustry, Vimedimex Medi – Pharma JSC's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vimedimex Medi – Pharma JSC Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vimedimex Medi – Pharma JSC's Net Margin % distribution charts can be found below:

* The bar in red indicates where Vimedimex Medi – Pharma JSC's Net Margin % falls into.


Vimedimex Medi – Pharma JSC Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Vimedimex Medi – Pharma JSC's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Vimedimex Medi – Pharma JSC's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Vimedimex Medi – Pharma JSC (STC:VMD) has a Net Margin % of 0.00% as of . 20. Net margin is the ratio of total net income to net sales. View historical data on Vimedimex Medi – Pharma JSC and its competitors.
Is Vimedimex Medi – Pharma JSC's Net Margin % too high?
Vimedimex Medi – Pharma JSC's current Net Margin % is 0.00%.
How does Vimedimex Medi – Pharma JSC's Net Margin % compare to GOVX and MBVXQ?
Vimedimex Medi – Pharma JSC's Net Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Vimedimex Medi – Pharma JSC and its competitors. Vimedimex Medi – Pharma JSC's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimedimex Medi – Pharma JSC stock overvalued right now?
Vimedimex Medi – Pharma JSC (STC:VMD) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Vimedimex Medi – Pharma JSC (STC:VMD), the current Net Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vimedimex Medi – Pharma JSC Business Description

Address 246 Cong Quynh Street, Pham Ngu Lao Ward, District 1, Ho Chi Minh City, VNM
Vimedimex Medi - Pharma JSC is engaged in the production, trading, import, and export of medicines, raw materials for making medicines, biological products, cosmetics, functional foodstuffs, medical equipment, and testing chemicals. It is also involved in renting office buildings; operates bonded warehouses and pharmacy-GSP.